Literature DB >> 21475547

NASH: The Hepatic injury of Metabolic syndrome: a brief update.

Ibrahim M1, Charanjit Singh, M Ashraf Ganie, K Alsayari.   

Abstract

Non alcoholic fatty liver disease occurs in those who don't consume alcohol in amounts considered harmful to the liver. It represents a spectrum of conditions characterized histologically by mainly macrovesicular hepatic steatosis. There are two histological patterns of NAFLD: fatty liver alone and steatohepatitis. In this brief review, clinical and histologic spectrum, natural history, diagnosis, and management of this condition are discussed.

Entities:  

Year:  2009        PMID: 21475547      PMCID: PMC3068809     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  24 in total

1.  The effects of 18 months of intermittent vs. continuous exercise on aerobic capacity, body weight and composition, and metabolic fitness in previously sedentary, moderately obese females.

Authors:  J E Donnelly; D J Jacobsen; K S Heelan; R Seip; S Smith
Journal:  Int J Obes Relat Metab Disord       Date:  2000-05

2.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

Authors:  P Angulo; J C Keach; K P Batts; K D Lindor
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

3.  Hepatic iron and nonalcoholic fatty liver disease.

Authors:  Z M Younossi; T Gramlich; B R Bacon; C A Matteoni; N Boparai; R O'Neill; A J McCullough
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

4.  Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations.

Authors:  Juliette Foucher; Laurent Castéra; Pierre-Henri Bernard; Xavier Adhoute; David Laharie; Julien Bertet; Patrice Couzigou; Victor de Lédinghen
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-04       Impact factor: 2.566

5.  Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus.

Authors:  K R Falchuk; S C Fiske; R C Haggitt; M Federman; C Trey
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

6.  Fatty changes in the liver: the relation to age, overweight and diabetes mellitus.

Authors:  P Hornbøll; T S Olsen
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1982-05

7.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

8.  Fatty liver hepatitis and cirrhosis in obese patients.

Authors:  M Adler; F Schaffner
Journal:  Am J Med       Date:  1979-11       Impact factor: 4.965

9.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  4 in total

1.  Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model.

Authors:  Aastha Arora; Gustavo Luis Tripodi; Ilona Kareinen; Martin Berg; Maria Josefa Forteza; Anton Gisterå; Silke Griepke; Felipe Beccaria Casagrande; Joilson O Martins; Dulcineia Saes Parra Abdalla; Jennifer Cole; Claudia Monaco; Daniel F J Ketelhuth
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

2.  Application of localized ³¹P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease.

Authors:  Ladislav Valkovič; Martin Gajdošík; Stefan Traussnigg; Peter Wolf; Marek Chmelík; Christian Kienbacher; Wolfgang Bogner; Michael Krebs; Michael Trauner; Siegfried Trattnig; Martin Krššák
Journal:  Eur Radiol       Date:  2014-03-20       Impact factor: 5.315

Review 3.  Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know!

Authors:  Ioannis A Ziogas; Konstantinos Zapsalis; Dimitrios Giannis; Georgios Tsoulfas
Journal:  World J Hepatol       Date:  2020-10-27

Review 4.  Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?

Authors:  Arshi Khanam; Paul G Saleeb; Shyam Kottilil
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.